Hypoxia-induced microRNA-155 promotes fibrosis in proximal tubule cells

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4555-4560

  Xie, Shenping ^a   Chen, Huaizhou ^a   Li, Fei ^a   Wang, Shu ^a   Guo, Junjun ^a  

^a Renal Transplantation and Dialysis Center   (China)

Author keywords

Fibrosis; Hypoxia; MicroRNA; MicroRNA 155

Indexed keywords

AUTOPHAGY PROTEIN 12; AUTOPHAGY PROTEIN 5; CASPASE; CASPASE 7; CASPASE 9; CELL PROTEIN; ROSCOVITINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG; ACTIN; ANTISENSE OLIGONUCLEOTIDE; CADHERIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CLEAVAGE; REGULATORY MECHANISM; ANTAGONISTS AND INHIBITORS; CELL HYPOXIA; CELL LINE; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; KIDNEY PROXIMAL TUBULE; METABOLISM; UPREGULATION;

ACTINS; CADHERINS; CELL HYPOXIA; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY TUBULES, PROXIMAL; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84924678349     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3327     Document Type: Article

References (40)

1. Higgins DF, Kimura K, Bernhardt, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117: 3810-3820, 2007.
2. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008.
3. Wynn TA: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529, 2007.
4. Romano E, Manetti M, Guiducci S, Ceccarelli C, Allanore Y and Matucci-Cerinic M: The genetics of systemic sclerosis: an update. Clin Exp Rheumatol 29: S75-S86, 2011.
5. Zell S, Schmitt R, Witting S, Kreipe HH, Hussein K and Becker JU: Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis. Nephron Extra 3: 50-58, 2013.
6. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011.
7. Li Y, Sun Y, Liu F, et al: Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition. PLoS One 8: e66356, 2013.
8. Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
9. Kriz W, Kaissling B and Le Hir M: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121: 468-474, 2011.
10. Barnes JL and Glass WF II: Renal interstitial fibrosis: a critical evaluation of the origin of myofibroblasts. Contrib Nephrol 169: 73-93, 2011.
11. Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222, 2010.
12. Nisticò P, Bissell MJ and Radisky DC: Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol 4: a011908, 2012.
13. López-Hernández FJ and López-Novoa JM: Role of TGF in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347: 141-154, 2012.
14. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C and Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363, 2002.
15. Berk BC, Fujiwara K and Lehoux S: ECM remodeling in hypertensive heart disease. J Clin Invest 117: 568-575, 2007.
16. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
17. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
18. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
19. Chau BN and Brenner DA: What goes up must come down: the emerging role of microRNA in fibrosis. Hepatology 53: 4-6, 2011.
20. Pinzani M, Rosselli M and Zuckermann M: Liver cirrhosis. Best Pract Res Clin Gastroenterol 25: 281-290, 2011.
21. Krenning G, Zeisberg EM and Kalluri R: The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225: 631-637, 2010.
22. Wynn TA: Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350, 2011.
23. Wang B, Koh P, Winbanks C, et al: miR-200a prevents renal fibrogenesis through repression of TGF2 expression. Diabetes 60: 280-287, 2011.
24. Zhong X, Chung AC, Chen HY, Meng XM and Lan HY: Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22: 1668-1681, 2011.
25. Kato M, Zhang J, Wang M, et al: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437, 2007.
26. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8: 64, 2010.
27. Wang H, Peng W, Shen X, Huang Y, Ouyang X and Dai Y: Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J Med Biol Res 45: 1308-1314, 2012.
28. Anglicheau D, Sharma VK, Ding R, et al: MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 106: 5330-5335, 2009.
29. Pottier N, Maurin T, Chevalier B, et al: Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 4: e6718, 2009.
30. Wang P, Hou J, Lin L, et al: Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 185: 6226-6233, 2010.
31. Singh P, Ricksten SE, Bragadottir G, Redfors B and Nordquist L: Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease. Clin Exp Pharmacol Physiol 40: 138-147, 2013.
32. Kishore R, Verma SK, Mackie AR, et al: Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PLoS One 8: e60161, 2013.
33. Harris AL: Hypoxia a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
34. Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408, 2012.
35. Greer SN, Metcalf JL, Wang Y and Ohh M: The updated biology of hypoxia-inducible factor. EMBO J 31: 2448-2460, 2012.
36. Higgins DF, Kimura K, Iwano M and Haase VH: Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 7: 1128-1132, 2008.
37. Bruning U, Cerone L, Neufeld Z, et al: MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol 31: 4087-4096, 2011.
38. Czyzyk-Krzeska MF and Zhang X: MiR-155 at the heart of oncogenic pathways. Oncogene 33: 677-678, 2014.
39. Hills CE and Squires PE: The role of TGF-beta and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 22: 131-139, 2011.
40. Kage H and Borok Z: EMT and interstitial lung disease: a mysterious relationship. Curr Opin Pulm Med 18: 517-523, 2012.